A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes

Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain

(2012) M. W. Ferenczy et al.   CLINICAL MICROBIOLOGY REVIEWS

JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy

(2012) Serena Delbue et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The clinical features of PML

(2011) J. R. BERGER   CLEVELAND CLINIC JOURNAL OF MEDICINE

Improved Survival of HIV-1-Infected Patients with Progressive Multifocal Leukoencephalopathy Receiving Early 5-Drug Combination Antiretroviral Therapy

(2011) Jacques Gasnault et al.   PLoS One

Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

(2010) Chen S Tan et al.   LANCET NEUROLOGY

The position of mefloquine as a 21st century malaria chemoprophylaxis

(2010) Patricia Schlagenhauf et al.   MALARIA JOURNAL

Progressive multifocal leukoencephalopathy and other forms of JC virus disease

(2010) Bruce J. Brew et al.   Nature Reviews Neurology

Identification and Characterization of Mefloquine Efficacy against JC Virus In Vitro

(2009) M. Brickelmaier et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY